A detailed history of Cutler Group LP transactions in Avita Medical, Inc. stock. As of the latest transaction made, Cutler Group LP holds 450 shares of RCEL stock, worth $4,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
450
Previous 450 -0.0%
Holding current value
$4,324
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$13.84 - $20.79 $5,951 - $8,939
-430 Reduced 48.86%
450 $6,000
Q2 2023

Jul 18, 2023

BUY
$10.7 - $17.48 $856 - $1,398
80 Added 10.0%
880 $14,000
Q1 2023

May 01, 2023

BUY
$6.45 - $14.48 $5,160 - $11,584
800 New
800 $11,000
Q1 2022

Apr 14, 2022

BUY
$6.96 - $12.15 $9,048 - $15,795
1,300 Added 650.0%
1,500 $12,000
Q4 2021

Jan 18, 2022

SELL
$11.72 - $19.66 $2,344 - $3,932
-200 Reduced 50.0%
200 $2,000
Q1 2021

Apr 26, 2021

BUY
$18.38 - $28.41 $7,352 - $11,364
400 New
400 $7,000

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $241M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.